A major challenge in treating cancer is the development of drug resistance, which can result
in treatment failure and tumor recurrence. Targeting cancer stem cells (CSCs) and non …

Cancer is a complex and high-mortality disease in the clinic. Cancer metastasis leads to
most cancer deaths. The therapeutics for cancer metastasis are greatly unsatisfactory now …

Platinum nanoparticles (PtNPs) offer significant promise in cancer therapy by enhancing the
therapeutic effects of platinum-based chemotherapies like cisplatin. These nanoparticles …

Abstract Introduction Matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9
(MMP-9) are critical components of the extracellular matrix (ECM) in colorectal cancer …

Mutant epidermal growth factor receptor (EGFR) signaling has emerged as a key cause of
carcinogenesis and therapy resistance in non‐small cell lung cancer (NSCLC), which …

Abstract Prostate apoptosis response‐4 (Par‐4) tumor suppressor protein has gained
attention as a potential therapeutic target owing to its unique ability to selectively induce …

Despite decades of basic and clinical research and trials of promising new therapies, cancer
remains a major cause of morbidity and mortality due to the emergence of drug resistance to …

Cancer is one of the most serious diseases that threaten human life and health. Among all
kinds of diseases, the mortality rate of malignant tumors is the second highest, second only …

Herbaspirillum huttiense is an opportunistic pathogen associated with rare cases of
bacteremia. In this case report, H huttiense was isolated from blood samples collected from …

Background: Breast cancer initiates when normal breast epithelial cells begin to replicate
unusually. These cells divide more rapidly than normal cells and continue to be …